Copyright © 2009 D. R. Cohen and N. Patel. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. G. Guyatt, J. Cairns, D. Churchill, et al., “Evidence-based medicine: a new approach to teaching the practice of medicine,” Journal of the American Medical Association, vol. 268, no. 17, pp. 2420–2425, 1992. View at Publisher · View at Google Scholar
2. National Institute for Clinical Excellence, Guide to the Methods of Technology Appraisal, National Institute for Clinical Excellence, London, UK, 2004.
3. National Institute for Health and Clinical Excellence, August 2009, http://www.nice.org.uk.
4. D. McDaid and J. Needle, “What use has been made of economic evaluation in public health? a systematic review of the literature,” in Future Public Health: Burdens, Challenges and Approaches, S. Dawson and S. Morris, Eds., Palgrave Macmillan, Basingstoke, UK, 2009.
5. M. F. Drummond and A. McGuire, Economic Evaluation in Health Care: Merging Theory with Practice, Oxford University Press, Oxford, UK, 2001.
6. National Institute for Health and Clinical Excellence, “Alzheimer's disease—donepezil, galantamine, rivastigmine (review) and memantine,” Technology Appraisal TA111, National Institute for Health and Clinical Excellence, London, UK, 2007.
7. M. Drummond, H. Weatherly, and B. Ferguson, “Economic evaluation of health interventions,” BMJ, vol. 337, p. a1204, 2008. View at Publisher · View at Google Scholar · View at Scopus
8. UK Faculty of Public Health, August 2010, http://www.fphm.org.uk.
9. S. Allin, E. Mossialos, M. McKee, and W. Holland, Making Decisions on Public Health: A Review of Eight Countries, World Health Organisation, Geneva, Switzerland, 2004.
10. M. L. Cropper and U. Subramanian, Public Choices between Life Saving Programs: How Important are Lives Saved?The World Bank Policy Research Department, Washington, DC, USA, 1995.
11. C. Donaldson, “The (near) equivalence of cost-effectiveness and cost-benefit analyses. Fact or fallacy?” PharmacoEconomics, vol. 13, no. 4, pp. 389–396, 1998. View at Publisher · View at Google Scholar · View at Scopus
12. P. O. Johansson, An Introduction to Modern Welfare Economics, University of Cambridge, Cambridge, UK, 2nd edition, 1991.
13. M. C. Auld, C. Donaldson, C. Mitton, and P. Shackley, “Health economics and public health,” in Oxford Textbook of Public Health, R. Detels, J. McEwen, R. Beaglehole, and H. Tanaka, Eds., Oxford University Press, Oxford, UK, 4th edition, 2002.
14. M. F. Drummond, H. L. A. Weatherly, K. Claxton, et al., Assessing the Challenges of Applying Standard Methods of Economic Evaluation to Public Health Interventions, University of York, York, UK, 2007.
15. K. Aunan, G. Pátzay, H. A. Aaheim, and H. M. Seip, “Health and environmental benefits from air pollution reductions in Hungary,” Science of the Total Environment, vol. 212, no. 2-3, pp. 245–268, 1998. View at Publisher · View at Google Scholar · View at Scopus
16. C. L. Miller, M. T. Schechter, E. Wood, et al., “The potential health and economic impact of implementing a medically prescribed heroin program among Canadian injection drug users,” International Journal of Drug Policy, vol. 15, no. 4, pp. 259–263, 2004. View at Publisher · View at Google Scholar · View at Scopus
17. J. P. Caulkins, S. S. Everingham, P. C. Rydell, J. Chiesa, and S. Bushway, An Ounce of Prevention, a Pound of Uncertainty: The Cost-Effectiveness of School-Based Drug Prevention Programs, RAND, Santa Monica, Calif, USA, 1999.
18. M. A. Cohen, “The monetary value of saving a high-risk youth,” Journal of Quantitative Criminology, vol. 14, no. 1, pp. 5–33, 1998.
19. M. F. Fleming, M. P. Mundt, M. T. French, L. B. Manwell, E. A. Stauffacher, and K. L. Barry, “Benefit-cost analysis of brief physician advice with problem drinkers in primary care settings,” Medical Care, vol. 38, no. 1, pp. 7–18, 2000.
20. J. Guria, “An economic evaluation of incremental resources to road safety programmes in New Zealand,” Accident Analysis and Prevention, vol. 31, no. 1-2, pp. 91–99, 1998.
21. B. Aehyung and B. Benton, “Cost benefit analysis of the onchocerciasis program,” World Bank Technical Paper 282, World Bank, Washington, DC, USA, 1995.
22. T. R. Miller and M. Galbraith, “Injury prevention counseling by pediatricians: a benefit-cost comparison,” Pediatrics, vol. 96, no. 1, pp. 1–4, 1995.
23. W. Zeng-Sui, D. S. Shepard, Z. Yun-Cheng, et al., “Reduction of enteric infectious disease in rural China by providing deep-well tap water,” Bulletin of the World Health Organization, vol. 67, no. 2, pp. 171–180, 1989.
24. G. M. Ginsberg and D. S. Silverberg, “A cost-benefit analysis of legislation for bicycle safety helmets in Israel,” American Journal of Public Health, vol. 84, no. 4, pp. 653–656, 1994. View at Scopus
25. M. F. Drummond, M. J. Sculpher, G. W. Torrance, G. L. Stoddart, and B. J. O'brien, Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press, Oxford, UK, 3rd edition, 2005.
26. Committee on Medial Aspects of Food and Nutrition Policy (COMA), Folic Acid and the Prevention of Disease, The Stationery Office, London, UK, 2000.
27. D. Cohen and J. Henderson, Health, Prevention and Economics, Oxford University Press, Oxford, UK, 1991.
28. National Institute for Health and Clinical Excellence, “Cost effectiveness of interventions for smoking cessation,” 2008, http://www.nice.org.uk/nicemedia/pdf/PH10CostEffectivenessModel.pdf.